EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting FOXP3 and Regulatory T Cells in Systemic Lupus Erythematosus: Emerging Therapeutic Strategies and Clinical Prospects

Shushu Du, Wenqi Xu, Lili Zhao, Xiaofei Shi, Rongzeng Liu iD

Journal of Cellular Biochemistry · 2026-09 · 127 (9)

DOI: 10.1002/jcb.70124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 08.09.2026. Verfasst von Shushu Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Forkhead Transcription Factors, T-Lymphocytes, Regulatory. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Young Backbone Teachers Training Program of Henan, Scientific Research Project of the Health Commission of Qingpu District, Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multi‐system involvement, and its pathogenesis is complex, involving abnormalities of multiple immune cells and molecules. In recent years, the role of the transcription factor Forkhead Box P3 (FOXP3) in SLE has attracted much attention. FOXP3, a crucial indicator of regulatory T cells (Tregs), is essential for maintaining immune tolerance and suppressing excessive immune responses. This review systematically elucidates the multi‐tiered regulatory networks that control FOXP3 expression at the transcriptional, epigenetic, and post‐translational levels. It further examines the specific phenotypic alterations and molecular mechanisms responsible for the dysregulation of Treg quantity, function, and stability within the SLE milieu, including factors such as interleukin (IL)‐2 deficiency, cytokine storms, and epigenetic abnormalities. Building upon this foundation, the article explores a range of emerging therapeutic strategies targeting FOXP3 and Tregs as central elements, highlighting recent advances and clinical translation prospects in low‐dose IL‐2 therapy, adoptive Treg cell transfer, and epigenetic drug interventions. Ultimately, we propose that the precise modulation and enhancement of Treg function to restore stable immune tolerance in SLE patients constitutes a novel therapeutic paradigm, transitioning from broad immunosuppression toward targeted immune modulation. This strategy holds significant promise for fundamentally improving the therapeutic landscape of this complex autoimmune disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicForkhead Transcription FactorsT-Lymphocytes, RegulatoryHumansAnimalsImmune ToleranceEpigenesis, GeneticInterleukin-2

Stichwörter der Autor:innen

FOXP3SLETregsimmunomodulationtherapeutic targets

Substanzen

Forkhead Transcription FactorsFOXP3 protein, humanInterleukin-2

Autor:innen und Institutionen

  • Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  • Qingpu Traditional Chinese Medicine Hospital, Shanghai, China.
  • The Third Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Key Laboratory of Clinical Immunology and Inflammatory Diseases, Luoyang, China.

ORCID-Profile: Rongzeng Liu

Förderung

  • National Natural Science Foundation of China
  • Young Backbone Teachers Training Program of Henan
  • Scientific Research Project of the Health Commission of Qingpu District, Shanghai

Zitieren

APA

Du, S., Xu, W., Zhao, L., Shi, X., & Liu, R. (2026). Targeting FOXP3 and Regulatory T Cells in Systemic Lupus Erythematosus: Emerging Therapeutic Strategies and Clinical Prospects. Journal of Cellular Biochemistry, 127(9). https://doi.org/10.1002/jcb.70124

Vancouver

Du S, Xu W, Zhao L, Shi X, Liu R. Targeting FOXP3 and Regulatory T Cells in Systemic Lupus Erythematosus: Emerging Therapeutic Strategies and Clinical Prospects. Journal of Cellular Biochemistry. 2026;127(9). doi:10.1002/jcb.70124

BibTeX
@article{Du2026,
  author = {Du, Shushu and Xu, Wenqi and Zhao, Lili and Shi, Xiaofei and Liu, Rongzeng},
  title = {Targeting FOXP3 and Regulatory T Cells in Systemic Lupus Erythematosus: Emerging Therapeutic Strategies and Clinical Prospects},
  journal = {Journal of Cellular Biochemistry},
  year = {2026},
  volume = {127},
  number = {9},
  doi = {10.1002/jcb.70124}
}
Kostenlos starten →